Changes to aspects of ongoing randomised controlled trials with fixed designs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Changes to aspects of ongoing randomised controlled trials with fixed designs ; volume:21 ; number:1 ; day:3 ; month:6 ; year:2020 ; pages:1-8 ; date:12.2020
Trials ; 21, Heft 1 (3.6.2020), 1-8, 12.2020
- Urheber
-
Coskinas, Xanthi
Simes, John
Schou, Manjula
Martin, Andrew James
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-020-04374-3
- URN
-
urn:nbn:de:101:1-2020080422243715337791
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Coskinas, Xanthi
- Simes, John
- Schou, Manjula
- Martin, Andrew James
- SpringerLink (Online service)
Ähnliche Objekte (12)
Overview of Ongoing Clinical Trials on Radioembolization
COVID-19: underpowered randomised trials, or no randomised trials?
Effect sizes in ongoing randomized controlled critical care trials
Sample size calculations for cluster randomised controlled trials with a fixed number of clusters
Increasing recruitment to randomised trials: a review of randomised controlled trials
Inadequate description of educational interventions in ongoing randomized controlled trials
Social and Psychological Aspects of Ongoing Changes in Japan : Introduction
Erratum to: Sample size calculations for cluster randomised controlled trials with a fixed number of clusters
A systematic review of ongoing clinical trials in optic pathway gliomas
Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Overview of Ongoing Clinical Trials on Radioembolization
COVID-19: underpowered randomised trials, or no randomised trials?
Effect sizes in ongoing randomized controlled critical care trials
Sample size calculations for cluster randomised controlled trials with a fixed number of clusters
Increasing recruitment to randomised trials: a review of randomised controlled trials
Inadequate description of educational interventions in ongoing randomized controlled trials
Social and Psychological Aspects of Ongoing Changes in Japan : Introduction
Erratum to: Sample size calculations for cluster randomised controlled trials with a fixed number of clusters
A systematic review of ongoing clinical trials in optic pathway gliomas
Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Overview of Ongoing Clinical Trials on Radioembolization
COVID-19: underpowered randomised trials, or no randomised trials?
Effect sizes in ongoing randomized controlled critical care trials
Sample size calculations for cluster randomised controlled trials with a fixed number of clusters
Increasing recruitment to randomised trials: a review of randomised controlled trials
Inadequate description of educational interventions in ongoing randomized controlled trials
Social and Psychological Aspects of Ongoing Changes in Japan : Introduction
Erratum to: Sample size calculations for cluster randomised controlled trials with a fixed number of clusters
A systematic review of ongoing clinical trials in optic pathway gliomas
Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials